Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 1, 2007, Pages 13-16

  Park, S Y ^a   Rhee, Y ^a   Youn, J C ^a   Park, Y N ^a   Lee, S ^a   Kim, D M ^a   Song, S Y ^a   Lim, S K ^a  

^a Yonsei University   (South Korea)

Author keywords

Adrenocorticotropic hormone; Corticotropin releasing hormone; Ectopic Cushing's syndrome; Gastrinoma

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ETOPOSIDE; GASTRIN; HYDROCORTISONE; MITOTANE; PACLITAXEL; PREDNISOLONE; SOMATOSTATIN DERIVATIVE;

ABDOMINAL RADIOGRAPHY; ADRENAL HYPERPLASIA; ADULT; AMENORRHEA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; CLIP; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DUODENAL ULCER BLEEDING; ECTOPIC CORTICOTROPIN PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRINOMA; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER METASTASIS; METABOLIC ALKALOSIS; MULTIPLE CYCLE TREATMENT; PANCREAS TUMOR; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; DUODENAL NEOPLASMS; ETOPOSIDE; FEMALE; GASTRINOMA; HUMANS; HYDROCORTISONE; LIVER NEOPLASMS; PACLITAXEL; PANCREATIC NEOPLASMS;

EID: 33847148079     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-948212     Document Type: Article

References (25)

1. de Herder WW, Krenning EP, van Eijck CHJ, Lamberts SWJ: Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas. Endocrine-Related Cancer 2004; 11: 19-34
2. Eriksson B, Renstrup J, Imam H, Oberg K: High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. Annals of Oncology 1997; 8: 1041-1044
3. Faiss S, Scherubl H, Riecken EO, Wiedenmann B: Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results in Cancer Research 1996; 142: 193-207
4. Faiss S, Pape UF, Bohmig M, Dorffel Y, Mansmann U, Golder W, Riecken EO, Wiedenmann B: Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol 2003; 21: 2689-2696
5. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM: Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clinical endocrinology 1986; 24: 699-713
6. Kurbacher CM, Cree IA: Chemosensitivity testing using microplate adenosine triphosphatebased luminescence measurements. Methods Mol Med 2005; 110: 101-120
7. Lamberts SW, de Herder WW, Krenning EP, Reubi JC: A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab 1994; 78: 17-19
8. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ: Octreotide. N Engl J Med 1996; 334: 246-254
9. Maton PN, Gardner JD, Jensen RT: Cushing's syndrome in patients with the Zollinger- Ellison syndrome. N Engl J Med 1986; 315: 1-5
10. Mitry E, Baudin D, Ducreux M, Sabourin JC, Rufie P, Aparicio T, Lasser P, Elias D, Duvillard P, Schlumberger M, Rougier P: Treatment of poorly differentiated neuroendocrine tumors with etoposide and cisplatin. British Journal of Cancer 1999; 81: 1351-1355
11. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 341: 635-644
12. Oberg K: Interferon in the management of neuroendocrine GEP-tumors: a review. Digestion 2000; 62 (Suppl 1):92-97
13. Oberg K: Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Annals of Oncology 2001; 12: S111-S114
14. O'Brien T, Young WF Jr, Davila DG, Scheithauer BW, Kovacs K, Horvath E, Vale W, Heerden JA: Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma. Clinical endocrinology 1992; 37: 460-467
15. Rickman T, Garmany R, Doherty T, Benson D, Okusa MD: Hypokalemia, metabolic alkalosis, and hypertension : Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. American journal of kidney diseases 2001; 347: 838-846
16. Saijo F, Naito H, Funayama Y, Fukushima K, Shibata C, Hashimoto A, Kitayama T, Nagao M, Matsuno S, Sasaki I: Octreotide in control of multiple liver metastases from gastrinoma. J Gastroenterol 2003; 38: 905-908
17. Schteingart DE, Lloyd RV, Akil H, Chandler WF, Ibarra-Perez G, Rosen SG, Ogletree R: Cushing's syndrome secondary to ectopic corticotropin- releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab 1986; 63: 770-775
18. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, Catargi B, Roger P, Laurent F: Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999; 84: 1193-1202
19. Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S: Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Jpn J Clin Oncol 1992; 22: 232-237
20. Vrezas I, Willenberg HS, Mansmann G, Hiroi N, Fritzen R, Bornstein SR: Ectopic adrenocorticotropin (ACTH) and corticotropin-releasing hormone (CRH) production in the adrenal gland: basic and clinical aspects. Microscopy research and technique 2003; 61: 308-314
21. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA: Ectopic adrenocorticotropic hormone syndrome. Endocrine reviews 1994; 15: 752-787
22. Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA: Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production. J Clin Oncol 1995; 13: 157-164
23. Young J, Deneux C, Grino M, Oliver C, Chanson P, Schaioson G: Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion. J Clin Endocrinol Metab 2005; 83: 305-308
24. Yu F, Venzon DJ, Serrano J, Serrano J, Goebel SU, Doppman JL, Gibril F, Jensen RT: Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999; 17: 615-630
25. Zarate A, Kovacs K, Flores M, Moran C, Felix I: ACTH and CRF-producing bronchial carcinoid associated with Cushing's syndrome. Clinical endocrinology 1986; 24: 523-529